In non-small cell lung cancer, BMS-690514, an inhibitor of human EGFR and vascular EGFR, induces G1 cell cycle arrest and stimulates caspase-dependent apoptosis through downregulation of HSP40 and other HSPs [166]. Here, EGFR is linked to non-small cell lung carcinoma.